Key Insights

Highlights

Treatment Research

3 treatments under study, led by Domperidone

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

2Total
Phase 3 (2)

Trial Status

Unknown1
Not Yet Recruiting1
Terminated1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06695962Phase 3Not Yet RecruitingPrimary

Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)

NCT03259256Phase 3UnknownPrimary

Islet Allotransplantation for Type 1 Diabetic Patients

NCT01530789TerminatedPrimary

Paramedical Consultation in Telemedicine

Showing all 3 trials

Research Network

Common Treatments

  • Domperidone1
  • Allogeneic Transplantation Of Intrahepatic Islet1
  • Gastric Emptying Test1

Active Sponsors

  • Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète1
  • Second Affiliated Hospital of Guangzhou Medical University1
  • University Hospital, Rouen1

Top Investigators

  • ping Xue, PhD1

    Second Affiliated Hospital of Guangzhou Medical University

Related Conditions

  • Type 1 Diabetic Patients1

Activity Timeline